Original Article
When to start secukinumab treatment in patients with axial spondyloarthropathy: Before or after anti-TNFα treatment?
¿Cuándo iniciar el tratamiento con secukinumab en pacientes con espondiloartropatía axial: antes o después del tratamiento anti-TNFα?
Tumay Aka,d, Leyla Mustafayevab,d, Yeliz Celikc, Ali Yagiz Aylac, Serdal Ugurluc,
Corresponding author
a Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
b Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Physical Therapy and Rehabilitation, Istanbul, Turkey
c Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey
Read
2774
Timeswas read the article
1182
Total PDF
1592
Total HTML
Share statistics
Article information
ISSN: 1699258XOriginal language: English
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2026 1 | 192 | 112 | 304 |
| 2025 12 | 187 | 159 | 346 |
| 2025 11 | 321 | 62 | 383 |
| 2025 10 | 20 | 67 | 87 |
| 2025 9 | 0 | 43 | 43 |
| 2025 8 | 0 | 75 | 75 |
| 2025 7 | 0 | 41 | 41 |
| 2025 6 | 0 | 21 | 21 |
| 2025 5 | 86 | 49 | 135 |
| 2025 4 | 57 | 32 | 89 |
| 2025 3 | 46 | 25 | 71 |
| 2025 2 | 57 | 40 | 97 |
| 2025 1 | 30 | 42 | 72 |
| 2024 12 | 22 | 23 | 45 |
| 2024 11 | 45 | 44 | 89 |
| 2024 10 | 36 | 18 | 54 |
| 2024 9 | 38 | 19 | 57 |
| 2024 8 | 44 | 32 | 76 |
| 2024 7 | 28 | 23 | 51 |
| 2024 6 | 50 | 27 | 77 |
| 2024 5 | 38 | 24 | 62 |
| 2024 4 | 35 | 24 | 59 |
| 2024 3 | 27 | 29 | 56 |
| 2024 2 | 31 | 19 | 50 |
| 2024 1 | 28 | 18 | 46 |
| 2023 12 | 33 | 26 | 59 |
| 2023 11 | 47 | 35 | 82 |
| 2023 10 | 60 | 34 | 94 |
| 2023 9 | 3 | 3 | 6 |
| 2023 8 | 3 | 0 | 3 |
| 2023 7 | 1 | 0 | 1 |
| 2023 6 | 1 | 1 | 2 |
| 2023 5 | 7 | 1 | 8 |
| 2023 4 | 12 | 7 | 19 |
| 2023 3 | 4 | 5 | 9 |
| 2023 2 | 1 | 0 | 1 |
| 2022 12 | 2 | 2 | 4 |
Show all
